구제역 시장 규모, 점유율, 성장 분석 : 백신 유형별, 동물 유형별, 유통 채널별, 지역별 - 산업 예측(2025-2032년)
FMD Disease Market Size, Share, and Growth Analysis, By Vaccine Type (Conventional vaccines, Emergency vaccines), By Animal Type (Cattle, Sheep & goat), By Distribution Channel, By Region - Industry Forecast 2025-2032
상품코드:1673695
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 03월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
구제역 시장 규모는 2023년에 32억 달러로 평가되며, 2024년 34억 8,000만 달러에서 2032년에는 68억 4,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 8.8%로 성장할 전망입니다.
세계 동물용 백신 시장, 특히 구제역(FMD) 백신 시장은 축산물 소비 증가와 가축 사육두수 증가로 인해 괄목할 만한 성장세를 보이고 있습니다. 환경의 변화와 세계화로 인해 가축 전염병과 인수공통전염병의 출현으로 세계 각국 정부는 가축과 가축에 대한 엄격한 위생 조치를 시행하도록 촉구하고 있습니다. 이러한 우려는 국가 경제에 심각한 영향을 미칠 수 있는 인수공통전염병의 발생을 방지하기 위한 규제 프레임워크에 반영되어 있습니다. 우유, 계란, 육류 등의 제품 수요 증가에 따른 투자 증가로 인해 FMD 백신 접종의 필요성은 잠재적인 발병으로 인한 경제적 손실을 줄이기 위해 가장 중요한 요소로 부각되고 있습니다. 그러나 북미와 유럽과 같은 지역에서는 FMD 발생을 효과적으로 억제하고 엄격한 동물 이동 규제를 통해 백신 접종의 필요성을 줄이고 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
구제역 시장 규모 : 백신 유형별 & CAGR(2025-2032)
시장 개요
기존 백신
수산화 알루미늄과 사포닌 기반 백신
오일 기반 백신
긴급 백신
구제역 시장 규모 : 동물 유형별 & CAGR(2025-2032)
시장 개요
소
양과 염소
돼지
기타 동물
구제역 시장 규모 : 유통 채널별 & CAGR(2025-2032)
시장 개요
동물병원·진료소
정부기관
소매 약국
온라인 약국
구제역 시장 규모 : 지역별 & CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Boehringer Ingelheim(Germany)
Merck Animal Health(USA)
Zoetis(USA)
MSD Animal Health(USA)
Elanco Animal Health(USA)
Ceva Sante Animale(France)
Virbac(France)
Indian Immunologicals Limited(India)
Biogenesis Bago(Argentina)
FMD Center World Reference Laboratory(UK)
TAD Pharma GmbH(Germany)
Vetoquinol(France)
Phibro Animal Health Corporation(USA)
Tiankang Bio(China)
Ringpu Biology(China)
CAVAC(China)
Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna(Italy)
Korea Animal Health Products Association(Korea)
CZ Veterinaria(Spain)
결론과 제안
KSA
영문 목차
영문목차
FMD Disease Market size was valued at USD 3.2 billion in 2023 and is poised to grow from USD 3.48 billion in 2024 to USD 6.84 billion by 2032, growing at a CAGR of 8.8% during the forecast period (2025-2032).
The global veterinary vaccine market, particularly for Foot-and-Mouth Disease (FMD) vaccines, is witnessing significant growth driven by increased animal product consumption and rising livestock populations. The emergence of livestock and zoonotic diseases, exacerbated by environmental changes and globalization, has prompted governments worldwide to implement stringent health measures for both domestic and livestock animals. This growing concern is reflected in regulatory frameworks aimed at preventing zoonotic outbreaks, which could severely impact national economies. With rising investments due to heightened demand for products like milk, eggs, and meat, the necessity for FMD vaccinations becomes paramount to mitigate financial losses from potential outbreaks. However, regions like North America and Europe have effectively controlled FMD incidents, reducing vaccination needs through strict animal movement regulations.
Top-down and bottom-up approaches were used to estimate and validate the size of the Fmd Disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Fmd Disease Market Segments Analysis
Global FMD Disease Market is segmented by Vaccine Type, Animal Type, Distribution Channel and region. Based on Vaccine Type, the market is segmented into Conventional vaccines and Emergency vaccines. Based on Animal Type, the market is segmented into Cattle, Sheep & goat, Pig and Other animals. Based on Distribution Channel, the market is segmented into Veterinary hospitals & clinics, Government institutions, Retail pharmacies and Online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Fmd Disease Market
The increasing demand for animal protein and dairy products significantly drives the FMD market, as foot-and-mouth disease (FMD) can lead to substantial economic losses within the livestock sector. As consumer preferences pivot towards animal-based nutrition, the necessity to maintain healthy livestock becomes crucial. Outbreaks of FMD can disrupt supply chains, result in culling, and diminish herd productivity, leading to increased urgency for effective vaccines and management strategies. Thus, addressing both FMD outbreaks and the rising demand for livestock products is essential for ensuring food security and stability in the agricultural economy, making it a pivotal factor influencing the FMD market.
Restraints in the Fmd Disease Market
The significant expense associated with FMD vaccines and diagnostic tests poses a considerable limitation on the Foot-and-Mouth Disease (FMD) market, especially in developing nations that boast substantial livestock populations. This financial burden restricts access to essential preventive measures and diagnostic tools, hindering effective management and control of the disease in regions where it is most needed. Consequently, the high costs can deter farmers and livestock owners from investing in vaccination programs, thereby increasing the vulnerability of their herds to outbreaks. As a result, the overall progress in mitigating FMD risks is adversely affected, compromising animal health and agricultural productivity.
Market Trends of the Fmd Disease Market
The FMD (Foot-and-Mouth Disease) market is witnessing a notable trend marked by a surge in demand for vaccines, primarily fueled by heightened awareness and proactive measures taken by governments in developing countries. As these nations strive to combat FMD outbreaks that threaten livestock health and agricultural productivity, investment in vaccination programs has intensified. Additionally, the rise in livestock trade and export activities amplifies the need for effective vaccination strategies, thereby driving market growth. Pharmaceutical companies are responding with innovative vaccine formulations and expanded production capacities, creating a dynamic landscape poised for substantial advancements in FMD prevention and control.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global FMD Disease Market Size by Vaccine Type & CAGR (2025-2032)
Market Overview
Conventional vaccines
Aluminium hydroxide & saponin-based vaccines
Oil-based vaccines
Emergency vaccines
Global FMD Disease Market Size by Animal Type & CAGR (2025-2032)
Market Overview
Cattle
Sheep & goat
Pig
Other animals
Global FMD Disease Market Size by Distribution Channel & CAGR (2025-2032)
Market Overview
Veterinary hospitals & clinics
Government institutions
Retail pharmacies
Online pharmacies
Global FMD Disease Market Size & CAGR (2025-2032)
North America (Vaccine Type, Animal Type, Distribution Channel)
US
Canada
Europe (Vaccine Type, Animal Type, Distribution Channel)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Vaccine Type, Animal Type, Distribution Channel)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Vaccine Type, Animal Type, Distribution Channel)
Brazil
Rest of Latin America
Middle East & Africa (Vaccine Type, Animal Type, Distribution Channel)
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Intelligence
Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
Company Details
Product Portfolio Analysis
Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
Boehringer Ingelheim (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Merck Animal Health (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Zoetis (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
MSD Animal Health (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Elanco Animal Health (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Ceva Sante Animale (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Virbac (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Indian Immunologicals Limited (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Biogenesis Bago (Argentina)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
FMD Center World Reference Laboratory (UK)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
TAD Pharma GmbH (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Vetoquinol (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Phibro Animal Health Corporation (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Tiankang Bio (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Ringpu Biology (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
CAVAC (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (Italy)
